Naamit Deshet-unger

Title: Naamit Deshet-Unger: Innovator in Cancer Treatment

Introduction

Naamit Deshet-Unger is a prominent inventor based in Ramat Gan, Israel. He has made significant contributions to the field of cancer treatment through his innovative research and development of T-cell therapies.

Latest Patents

Deshet-Unger holds a patent for "T-cells comprising two different chimeric antigen receptors and uses thereof." This invention provides T-cells modified to express at least two chimeric antigen receptors. One of the CARs binds specifically to an antigen selected from CD138, HER2, and CD24, while another CAR binds specifically to a different antigen selected from the same list. The invention also includes pharmaceutical compositions comprising these CAR T-cells and their use in the treatment of cancer, particularly ovarian cancer. Additionally, it covers DNA constructs encoding the CARs and methods for preparing T-cells expressing these CARs. He has 1 patent to his name.

Career Highlights

Throughout his career, Deshet-Unger has worked with notable organizations, including the Medical Research Infrastructure and Health Services Fund of the Tel Aviv Medical Center and Yeda Research and Development Company Ltd. His work has been instrumental in advancing the understanding and application of CAR T-cell therapies.

Collaborations

Some of his notable coworkers include Zelig Eshhar and Tova Waks, who have collaborated with him on various research projects.

Conclusion

Naamit Deshet-Unger is a key figure in the development of innovative cancer treatments through his work on T-cell therapies. His contributions continue to impact the field of oncology significantly.